Brief: Shanghai Haohai Biological Technology Sees HY Profit Attributable Between RMB182 Mln-RMB200 Mln
05/07/2019 01:00
July 5 (Reuters) - Shanghai Haohai Biological Technology Co
Ltd 6826.HK :
* QTRLY PROFIT ATTRIBUTABLE TO OWNERS RMB 66.6 MILLION
VERSUS RMB
63.6 MILLION
* EXPECTS TO RECORD REVENUE IN RANGE FROM ABOUT RMB767.00
MILLION
TO RMB800.00 MILLION FOR SIX MONTHS ENDED 30 JUNE
* PROFIT ATTRIBUTABLE EXPECTED TO BE IN RANGE OF RMB182.00
MILLION
TO RMB200.00 MILLION FOR SIX MONTHS ENDED 30 JUNE
Source text for Eikon: urn:newsml:reuters.com:*:nHKS3njf9v
Further company coverage: 6826.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.